Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025 – Bristol Myers Squibb

  1. Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025  Bristol Myers Squibb
  2. Will Camzyos Strengthen BMY’s Cardiovascular Portfolio?  Yahoo Finance
  3. Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025  BioSpace

Continue Reading